Keywords:
ксенотрансплантат, перикард, Van Gieson, коллаген, CD31, Ki-67, Bcl-2, Vimentin, ангиогенез, фибробласт, бириктирувчи тўқима, ремоделланиш.References
1. Gilbert T.W., Sellaro T.L., Badylak S.F. Decellularization of tissues and organs. Biomaterials. 2006;27(19):3675–3683. doi:10.1016/j.biomaterials.2006.02.014.
2. Badylak S.F. The extracellular matrix as a biologic scaffold material. Biomaterials. 2007;28 (25):3587-3593.
3. Badylak S.F., Gilbert T.W. Immune response to biologic scaffold materials. Seminars in Immunology. 2008;20(2):109–116.
4. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Seminars in Immunology. 2008;20(2):86–100. doi: 10.1016/ j.smim. 2007.11.004.
5. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Engineering Part A. 2008;14(11):1835–1842.
6. Brown B.N., Valentin J.E., Stewart-Akers A.M., McCabe G.P., Badylak S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without cellular components. Biomaterials. 2009;30(8):1482–1491.
7. Valentin J.E., Stewart-Akers A.M., Gilbert T.W., Badylak S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Engineering Part A. 2009.
8. Crapo P.M., Gilbert T.W., Badylak S.F. An overview of tissue and whole organ decellularization processes. Biomaterials. 2011;32(12):3233–3243.
9. Brown B.N., Londono R., Tottey S., et al. Macrophage phenotype as a predictor of constructive remodeling following implantation of biologically derived surgical mesh materials. Acta Biomaterialia. 2012;8(3):978–987.
10. Dziki J.L., Huleihel L., Scarritt M.E., Badylak S.F. Extracellular matrix bioscaffolds as immunomodulatory biomaterials. Tissue Engineering Part A. 2017;23(19–20):1152–1159.
11. Dziki J.L., Wang D.S., Pineda C., et al. Solubilized extracellular matrix bioscaffolds derived from diverse source tissues differentially influence macrophage phenotype. J Biomed Mater Res A. 2017;105(1):138–147.
12. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature. 2008;453(7193):314–321.
13. Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Medicine. 2012;18(7):1028–1040.
14. Parenteau-Bareil R., Gauvin R., Berthod F. Collagen-based biomaterials for tissue engineering applications. Materials. 2010;3(3):1863–1887.
15. Keane T.J., Swinehart I.T., Badylak S.F. Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance. Methods. 2015;84:25–34.
16. Witherel C.E., Graney P.L., Freytes D.O., Weingarten M.S., Spiller K.L. Response of human macrophages to wound matrices in vitro. Wound Repair Regen. 2016;24(3):514–524.
17. Ashurko I., Tarasenko S., Magdalyanova M., et al. Comparative analysis of xenogeneic collagen matrix and autogenous subepithelial connective tissue graft to increase soft tissue volume around dental implants: a systematic review and meta-analysis. BMC Oral Health. 2023;23:741.
18. Dadlani S., Joseph B., Anil S., et al. Efficacy of xenogeneic collagen matrices in augmenting peri-implant soft tissue: a systematic review and meta-analysis. Clinical and Experimental Dental Research. 2024;10:e937.
19. Cao L., Zhang Z., Yuan D., et al. Tissue engineering applications of recombinant human collagen: a review of recent progress. Front Bioeng Biotechnol. 2024;12:1358246.
20. Esmaeili A., Soleimani M., Rouhani M., et al. Xenograft-based skin substitutes: a critical review. Journal of Drug Delivery Science and Technology. 2024;95:105613.
